Beth Moulaison

Beth Moulaison is a seasoned professional in the fields of quality assurance and compliance, currently serving as Sr. Director/Head of Research and Development, Bioanalytical and GLP Quality at Intellia Therapeutics, Inc. since January 2023. With a substantial background at Vertex Pharmaceuticals, spanning over six years in various leadership roles, including Sr. Director of R&D Quality and Audit and Inspection Management, Beth has developed and executed strategic oversight for research, biomarker development, and compliance programs. Prior positions include strategic roles at Shire, Charles River Laboratories, and Genzyme, focusing on internal process compliance and quality assurance across multiple regulatory frameworks. Beth holds a Bachelor of Science in Chemistry from Dalhousie University and a Bachelor of Education in Secondary Math and Science from St. Francis Xavier University.